Sculptor Capital LP Kala Pharmaceuticals, Inc. Transaction History

Sculptor Capital LP

  • $2.76 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$1.16 - $2.74 $56,839 - $134,260
-49,000 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$6.24 - $9.58 $222,144 - $341,048
35,600 Added 265.67%
49,000 $330,000
Q2 2020

Aug 14, 2020
SELL
$8.33 - $13.79 $414,001 - $685,363
-49,700 Reduced 78.76%
13,400 $140,000
Q1 2020

May 14, 2020
BUY
$3.83 - $8.79 $241,673 - $554,649
63,100 New
63,100 $554,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $8.67M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Sculptor Capital LP Portfolio

Follow Sculptor Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Sculptor Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email